These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29555827)

  • 1. A Clinical Quantitative Evaluation of Hepatobiliary Transport of [
    Kaneko K; Tanaka M; Ishii A; Katayama Y; Nakaoka T; Irie S; Kawahata H; Yamanaga T; Wada Y; Miyake T; Toshimoto K; Maeda K; Cui Y; Enomoto M; Kawamura E; Kawada N; Kawabe J; Shiomi S; Kusuhara H; Sugiyama Y; Watanabe Y
    Drug Metab Dispos; 2018 May; 46(5):719-728. PubMed ID: 29555827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats.
    Shingaki T; Takashima T; Ijuin R; Zhang X; Onoue T; Katayama Y; Okauchi T; Hayashinaka E; Cui Y; Wada Y; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
    J Pharmacol Exp Ther; 2013 Oct; 347(1):193-202. PubMed ID: 23926287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography studies using (15R)-16-m-[11C]tolyl-17,18,19,20-tetranorisocarbacyclin methyl ester for the evaluation of hepatobiliary transport.
    Takashima T; Nagata H; Nakae T; Cui Y; Wada Y; Kitamura S; Doi H; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
    J Pharmacol Exp Ther; 2010 Nov; 335(2):314-23. PubMed ID: 20716623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [¹¹C]telmisartan.
    Takashima T; Hashizume Y; Katayama Y; Murai M; Wada Y; Maeda K; Sugiyama Y; Watanabe Y
    Mol Pharm; 2011 Oct; 8(5):1789-98. PubMed ID: 21812443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me.
    Takashima T; Kitamura S; Wada Y; Tanaka M; Shigihara Y; Ishii H; Ijuin R; Shiomi S; Nakae T; Watanabe Y; Cui Y; Doi H; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
    J Nucl Med; 2012 May; 53(5):741-8. PubMed ID: 22499612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography.
    Hernández Lozano I; Karch R; Bauer M; Blaickner M; Matsuda A; Wulkersdorfer B; Hacker M; Zeitlinger M; Langer O
    AAPS J; 2019 Apr; 21(4):61. PubMed ID: 31037511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical Synthesis of [
    Nakaoka T; Uetake Y; Kaneko KI; Niwa T; Ochiai H; Irie S; Suezaki Y; Otsuka N; Hayashinaka E; Wada Y; Cui Y; Maeda K; Kusuhara H; Sugiyama Y; Hosoya T; Watanabe Y
    Mol Pharm; 2020 Jun; 17(6):1884-1898. PubMed ID: 32271581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of transporter-mediated hepatobiliary transport of newly developed
    Kimura H; Yagi Y; Mikamo M; Maeda K; Kagawa S; Arimitsu K; Higashi T; Nishii R; Ono M; Nakamoto Y; Togashi K; Kusuhara H; Saji H
    Drug Metab Pharmacokinet; 2019 Oct; 34(5):317-324. PubMed ID: 31331824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of breast cancer resistance protein function in hepatobiliary and renal excretion using PET with 11C-SC-62807.
    Takashima T; Wu C; Takashima-Hirano M; Katayama Y; Wada Y; Suzuki M; Kusuhara H; Sugiyama Y; Watanabe Y
    J Nucl Med; 2013 Feb; 54(2):267-76. PubMed ID: 23287578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
    Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K
    Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of in vivo biliary clearance from the in vitro transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II monolayer expressing both rat organic anion transporting polypeptide 4 and multidrug resistance associated protein 2.
    Sasaki M; Suzuki H; Aoki J; Ito K; Meier PJ; Sugiyama Y
    Mol Pharmacol; 2004 Sep; 66(3):450-9. PubMed ID: 15322236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice.
    Neyt S; Huisman MT; Vanhove C; De Man H; Vliegen M; Moerman L; Dumolyn C; Mannens G; De Vos F
    J Nucl Med; 2013 Apr; 54(4):624-30. PubMed ID: 23440558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
    Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
    Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.
    Ghibellini G; Leslie EM; Pollack GM; Brouwer KL
    Pharm Res; 2008 Aug; 25(8):1851-60. PubMed ID: 18509604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
    Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the transporters involved in the hepatobiliary transport and intestinal efflux of methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) glucuronide, a pharmacologically active metabolite of S-8921.
    Sakamoto S; Kusuhara H; Horie K; Takahashi K; Baba T; Ishizaki J; Sugiyama Y
    Drug Metab Dispos; 2008 Aug; 36(8):1553-61. PubMed ID: 18474677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
    Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Modeling of the Hepatic Disposition of Estradiol-17
    Ito K; Sjöstedt N; Brouwer KLR
    Drug Metab Dispos; 2020 Feb; 48(2):116-122. PubMed ID: 31744810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Evaluation of mMate1 Function Based on Minimally Invasive Measurement of Tissue Concentration Using PET with [(11)C]Metformin in Mouse.
    Shingaki T; Hume WE; Takashima T; Katayama Y; Okauchi T; Hayashinaka E; Wada Y; Cui Y; Kusuhara H; Sugiyama Y; Watanabe Y
    Pharm Res; 2015 Aug; 32(8):2538-47. PubMed ID: 25715695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism.
    Sheng J; Tian X; Xu G; Wu Z; Chen C; Wang L; Pan L; Huang C; Pan G
    Drug Metab Dispos; 2015 Jan; 43(1):63-72. PubMed ID: 25336752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.